LYEL
Price
$0.61
Change
-$0.01 (-1.61%)
Updated
Dec 24 closing price
63 days until earnings call
PRME
Price
$2.76
Change
-$0.05 (-1.78%)
Updated
Dec 24 closing price
71 days until earnings call
Ad is loading...

LYEL vs PRME

Header iconLYEL vs PRME Comparison
Open Charts LYEL vs PRMEBanner chart's image
Lyell Immunopharma
Price$0.61
Change-$0.01 (-1.61%)
Volume$742.28K
CapitalizationN/A
Prime Medicine
Price$2.76
Change-$0.05 (-1.78%)
Volume$563.35K
CapitalizationN/A
LYEL vs PRME Comparison Chart
Loading...
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LYEL vs. PRME commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LYEL is a Hold and PRME is a Hold.

Ad is loading...
COMPARISON
Comparison
Dec 25, 2024
Stock price -- (LYEL: $0.61 vs. PRME: $2.76)
Brand notoriety: LYEL and PRME are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LYEL: 41% vs. PRME: 49%
Market capitalization -- LYEL: $179.07M vs. PRME: $362M
LYEL [@Biotechnology] is valued at $179.07M. PRME’s [@Biotechnology] market capitalization is $362M. The market cap for tickers in the [@Biotechnology] industry ranges from $385.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.4B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LYEL’s FA Score shows that 0 FA rating(s) are green whilePRME’s FA Score has 0 green FA rating(s).

  • LYEL’s FA Score: 0 green, 5 red.
  • PRME’s FA Score: 0 green, 5 red.
According to our system of comparison, both LYEL and PRME are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LYEL’s TA Score shows that 4 TA indicator(s) are bullish while PRME’s TA Score has 4 bullish TA indicator(s).

  • LYEL’s TA Score: 4 bullish, 5 bearish.
  • PRME’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both LYEL and PRME are a bad buy in the short-term.

Price Growth

LYEL (@Biotechnology) experienced а -5.11% price change this week, while PRME (@Biotechnology) price change was -5.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.85%. For the same industry, the average monthly price growth was -1.81%, and the average quarterly price growth was +3.32%.

Reported Earning Dates

LYEL is expected to report earnings on Feb 26, 2025.

PRME is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (-0.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRME($362M) has a higher market cap than LYEL($179M). LYEL (-68.407) and PRME (-68.849) have similar YTD gains . LYEL (-197.45M) and PRME (-207.13M) have comparable annual earnings (EBITDA) . LYEL has more cash in the bank: 441M vs. PRME (176M). PRME has less debt than LYEL: PRME (41.2M) vs LYEL (51.4M). PRME has higher revenues than LYEL: PRME (800K) vs LYEL (63K).
LYELPRMELYEL / PRME
Capitalization179M362M49%
EBITDA-197.45M-207.13M95%
Gain YTD-68.407-68.84999%
P/E RatioN/AN/A-
Revenue63K800K8%
Total Cash441M176M251%
Total Debt51.4M41.2M125%
FUNDAMENTALS RATINGS
PRME: Fundamental Ratings
PRME
OUTLOOK RATING
1..100
71
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LYELPRME
RSI
ODDS (%)
Bullish Trend 1 day ago
67%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 6 days ago
90%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 24 days ago
83%
Bullish Trend 6 days ago
76%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
67%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
LYEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VSORX47.420.42
+0.89%
Victory Sycamore Small Company Opp R6
BAEIX22.010.16
+0.73%
Sterling Capital Equity Income A
AIEAX14.760.04
+0.27%
American Beacon International Eq A
MRVNX12.040.03
+0.25%
Mirova International Sustainable Eq N
MSTGX9.29N/A
N/A
Morningstar Global Income

LYEL and

Correlation & Price change

A.I.dvisor indicates that over the last year, LYEL has been loosely correlated with VCYT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if LYEL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LYEL
1D Price
Change %
LYEL100%
-0.44%
VCYT - LYEL
46%
Loosely correlated
+0.46%
NTLA - LYEL
44%
Loosely correlated
-0.41%
RCKT - LYEL
44%
Loosely correlated
+2.19%
PRME - LYEL
43%
Loosely correlated
-1.78%
ALLO - LYEL
41%
Loosely correlated
+7.18%
More

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been loosely correlated with CRSP. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if PRME jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
-1.78%
CRSP - PRME
62%
Loosely correlated
+1.14%
BEAM - PRME
61%
Loosely correlated
+0.38%
NTLA - PRME
59%
Loosely correlated
-0.41%
RXRX - PRME
56%
Loosely correlated
+3.58%
ABCL - PRME
54%
Loosely correlated
+1.03%
More